Personal or first-degree relative(s) history of multiple endocrine neoplasia type 2 or medullary thyroid carcinoma
TRANSCEND-T2D-1 also reported improvements in non-HDL cholesterol, triglycerides, and systolic blood pressure, but these are risk markers rather than proof of fewer heart attacks, strokes, kidney outcomes, or heart failure events [9]
By understanding your genetic predisposition to GLP-1 sensitivity and peptide pathway function, PlexusDx-affiliated clinicians can tailor your starting dose, escalation schedule, and medication choice to minimize uncomfortable transitions
Monitor side effects: If nausea, fatigue, bloating, or indigestion happen after your injection, choose a time or day when you have fewer responsibilities
Trial on the Biological and Clinical Effects of Acetyl-L-carnitine in ALS (ALCALS) 2025
The effect of CNQX on self-administration: present in nicotine, absent in methamphetamine model